DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Sequist LV, Yang JC, Yamamoto N et al.
Phase III study of afatinib or cisplatin plus pemetrexed in patients with metastatic lung adenocarcinoma with EGFR mutations.
J Clin Oncol 2013;
31: 3327-3334
We do not assume any responsibility for the contents of the web pages of other providers.